5HT2C receptor modulators
US8993750B2 · kind B2 · utility
3Cited by
32References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 9, 2014 |
| Grant date | Mar 31, 2015 |
| Priority date | — |
| Expiry date | Jul 9, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel compounds of Formula (I):which act as 5HT2C receptor modulators. These compounds are useful in pharmaceutical compositions whose use includes the treatment of obesity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.